Patient-Based Therapeutics
AcuraStem is a near-to-clinic, patient-based, biotechnology company pioneering how treatments are developed for neurodegenerative diseases — including sporadic ALS and FTD — using our proprietary, best-in-class, disease-modeling platform, iNeuroRx®, the gold standard for discovering novel, effective and broadly-acting treatments.
Patient Focused
learn about our work
Neurodegenerative Disease Areas



Latest News
AcuraStem was honored to once again partner with Team Nanci and the ALS Association Golden West Chapter in the fight against ALS as a sponsor of the 17th Annual Los Angeles County Walk to Defeat ALS® on Sunday, November 3, at Exposition Park in Los Angeles.
Nov 3rd, 2019, Walk to Defeat ALS, Golden West Chapter: Team AcuraStem is fundraising for Team Nanci and the whole team will walk in LA on November 3rd. Come by our booth!
October 26th, 2019, UCLA California NanoSystems Institute: CEO, Co-Founder Sam Alworth Presenting at the 5th Annual BCLA Biotech Summit "Mapping out LA’s Biotech Landscape"